Pictet Asset Management Sa Neurocrine Biosciences Inc Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 924,416 shares of NBIX stock, worth $126 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
924,416
Previous 724,244
27.64%
Holding current value
$126 Million
Previous $73.3 Million
18.91%
% of portfolio
0.1%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.34 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$761 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$611 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$422 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...